Keywords: lilly, reopro/stent, better, activase, eli, glycoprotein, iia/iiib

Lilly's ReoPro/stent better than Activase

Article | 11 August 2000

Print This

Eli Lilly's glycoprotein IIa/IIIb inhibitor ReoPro (abciximab) pluscoronary stenting has been shown to be more effective in limiting damage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in